291 related articles for article (PubMed ID: 38338724)
1. How to Use the Cuprizone Model to Study De- and Remyelination.
Kipp M
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338724
[TBL] [Abstract][Full Text] [Related]
2. A new model of cuprizone-mediated demyelination/remyelination.
Sachs HH; Bercury KK; Popescu DC; Narayanan SP; Macklin WB
ASN Neuro; 2014; 6(5):. PubMed ID: 25290063
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the Genetic Crosstalk between Microglia and Oligodendrocyte Precursor Cells during Demyelination and Remyelination Using Transcriptomic Data.
Enrich-Bengoa J; Manich G; Dégano IR; Perálvarez-Marín A
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499195
[TBL] [Abstract][Full Text] [Related]
4. Laquinimod Supports Remyelination in Non-Supportive Environments.
Nyamoya S; Steinle J; Chrzanowski U; Kaye J; Schmitz C; Beyer C; Kipp M
Cells; 2019 Oct; 8(11):. PubMed ID: 31683658
[TBL] [Abstract][Full Text] [Related]
5. EBI2 is expressed in glial cells in multiple sclerosis lesions, and its knock-out modulates remyelination in the cuprizone model.
Klejbor I; Shimshek DR; Klimaszewska-Łata J; Velasco-Estevez M; Moryś J; Karaszewski B; Szutowicz A; Rutkowska A
Eur J Neurosci; 2021 Aug; 54(3):5173-5188. PubMed ID: 34145920
[TBL] [Abstract][Full Text] [Related]
6. p38γ MAPK delays myelination and remyelination and is abundant in multiple sclerosis lesions.
Marziali LN; Hwang Y; Palmisano M; Cuenda A; Sim FJ; Gonzalez A; Volsko C; Dutta R; Trapp BD; Wrabetz L; Feltri ML
Brain; 2024 May; 147(5):1871-1886. PubMed ID: 38128553
[TBL] [Abstract][Full Text] [Related]
7. Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination.
Butti E; Bacigaluppi M; Chaabane L; Ruffini F; Brambilla E; Berera G; Montonati C; Quattrini A; Martino G
J Neurosci; 2019 Jul; 39(28):5481-5492. PubMed ID: 31138656
[TBL] [Abstract][Full Text] [Related]
8. Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
Acs P; Komoly S
Ideggyogy Sz; 2012 Jul; 65(7-8):266-70. PubMed ID: 23074847
[TBL] [Abstract][Full Text] [Related]
9. N-butyl-β-carboline-3-carboxylate (β-CCB) systemic administration promotes remyelination in the cuprizone demyelinating model in mice.
Vélez-Uriza F; Ordaz RP; Garay E; Cisneros-Mejorado AJ; Arellano RO
Sci Rep; 2024 Jun; 14(1):13988. PubMed ID: 38886527
[TBL] [Abstract][Full Text] [Related]
10. The roles of microglia and astrocytes in phagocytosis and myelination: Insights from the cuprizone model of multiple sclerosis.
Sen MK; Mahns DA; Coorssen JR; Shortland PJ
Glia; 2022 Jul; 70(7):1215-1250. PubMed ID: 35107839
[TBL] [Abstract][Full Text] [Related]
11. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
[TBL] [Abstract][Full Text] [Related]
12. Amyloid precursor protein and amyloid precursor-like protein 2 have distinct roles in modulating myelination, demyelination, and remyelination of axons.
Truong PH; Ciccotosto GD; Merson TD; Spoerri L; Chuei MJ; Ayers M; Xing YL; Emery B; Cappai R
Glia; 2019 Mar; 67(3):525-538. PubMed ID: 30506868
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine kinase 2 is essential for remyelination following cuprizone intoxication.
Song H; McEwen HP; Duncan T; Lee JY; Teo JD; Don AS
Glia; 2021 Dec; 69(12):2863-2881. PubMed ID: 34399014
[TBL] [Abstract][Full Text] [Related]
14. G-Protein-Coupled Receptor Gpr17 Expression in Two Multiple Sclerosis Remyelination Models.
Nyamoya S; Leopold P; Becker B; Beyer C; Hustadt F; Schmitz C; Michel A; Kipp M
Mol Neurobiol; 2019 Feb; 56(2):1109-1123. PubMed ID: 29873041
[TBL] [Abstract][Full Text] [Related]
15. Total astragalosides promote oligodendrocyte precursor cell differentiation and enhance remyelination in cuprizone-induced mice through suppression of Wnt/β-catenin signaling pathway.
Yuan J; Xu N; Tao Y; Han X; Yang L; Liang J; Jin H; Zhang X; Wu H; Shi H; Huang F; Wu X
J Ethnopharmacol; 2022 Nov; 298():115622. PubMed ID: 35964820
[TBL] [Abstract][Full Text] [Related]
16. Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period.
Zhang M; Zhan XL; Ma ZY; Chen XS; Cai QY; Yao ZX
Exp Biol Med (Maywood); 2015 Sep; 240(9):1183-96. PubMed ID: 25577802
[TBL] [Abstract][Full Text] [Related]
17. Pivotal role of choline metabolites in remyelination.
Skripuletz T; Manzel A; Gropengießer K; Schäfer N; Gudi V; Singh V; Salinas Tejedor L; Jörg S; Hammer A; Voss E; Vulinovic F; Degen D; Wolf R; Lee DH; Pul R; Moharregh-Khiabani D; Baumgärtner W; Gold R; Linker RA; Stangel M
Brain; 2015 Feb; 138(Pt 2):398-413. PubMed ID: 25524711
[TBL] [Abstract][Full Text] [Related]
18. Butyrate suppresses demyelination and enhances remyelination.
Chen T; Noto D; Hoshino Y; Mizuno M; Miyake S
J Neuroinflammation; 2019 Aug; 16(1):165. PubMed ID: 31399117
[TBL] [Abstract][Full Text] [Related]
19. Regulatory effect of triiodothyronine on brain myelination and astrogliosis after cuprizone-induced demyelination in mice.
Zendedel A; Kashani IR; Azimzadeh M; Pasbakhsh P; Omidi N; Golestani A; Beyer C; Clarner T
Metab Brain Dis; 2016 Apr; 31(2):425-33. PubMed ID: 26725831
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of Protein Tyrosine Phosphatase Receptor Type Z by Pleiotrophin Promotes Remyelination through Activation of Differentiation of Oligodendrocyte Precursor Cells.
Kuboyama K; Fujikawa A; Suzuki R; Noda M
J Neurosci; 2015 Sep; 35(35):12162-71. PubMed ID: 26338327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]